Spastic Hemiparesis Clinical Trial
— ADJU-TOXOfficial title:
Randomised Controlled Trial to Evaluate the Effect of a Self-rehabilitation Program in Addition to Usual Treatment for Spasticity (Repeated Botulinum Toxin Injections and Physiotherapy) on Impairment and Activity Limitation in Patients With Spastic Hemiparesis Following Stroke
The addition of a self-rehabilitation program to repeated Botulinum Toxin Injections (BTI) and usual physiotherapy should increase the proportion of patients who attain their Primary Treatment Goal (impairments and function) more than usual care (involving repeated Botulinum Toxin Injections and conventional physiotherapy), in post stroke out-patients with spasticity.
Status | Recruiting |
Enrollment | 220 |
Est. completion date | January 3, 2021 |
Est. primary completion date | December 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: 1. Males and females aged between 18 to 75 years. 2. Adult patient under guardianship with consent obtained and the legal guardian's authorisation obtained. 3. Single stroke having occurred more than 6 months before (previous TIA is accepted). 4. Capable of understanding instructions and participating in the definition of a therapeutic goal (Boston Diagnostic Aphasia Examination (BDAE) < 3). 5. Having previously undergone BTI. The last injection must have been performed at least 4 months prior to inclusion. 6. Affiliation to the French social security regime or a similar regime. 7. Patient (or the legal guardian if under guardian adult patient) has signed the informed consent form. Exclusion Criteria: 1. Patients who are unwilling to participate in the study. For the one under guardianship, the refusal of the patient will be the final decision even if the guardian is willing to participate. 2. Subjects who are unlikely to adhere to the study an/or poor adherence anticipated by the investigator. 3. Un-controlled progressive pathology. 4. Osteoarticular lesion which contraindicates part of the rehabilitation involved in the study. 5. Patients with other interventions planned prior to the end of the study period (orthosis, surgery etc.). 6. Surgery to the treated limb less than 6 months previously. 7. Pregnant woman. |
Country | Name | City | State |
---|---|---|---|
France | Hôpital Raymond Poincaré | Garches |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Assessment of Goal Attainment Scaling (GAS). | The percentage of patients who attain their Primary Treatment Goal determined using Goal Attainment Scaling (GAS) at each visits and in both groups. | 6 months | |
Secondary | Assessment of the Functional Independence Measure (FIM) | 6 months | ||
Secondary | Assessment of Hemispatial neglect | 6 months | ||
Secondary | Quality of life questionnaire | 6 months | ||
Secondary | Assessment of slight deficits according MOCA scale (Montréal Cognitive Assessment) | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05436366 -
Soleus Loading Response During Walking
|
N/A | |
Completed |
NCT05546190 -
A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)
|
||
Completed |
NCT03549975 -
Hand Rehabilitation Using Botulinum Toxin and Functional Electrical Stimulation-pilot Study
|
Phase 4 | |
Active, not recruiting |
NCT06001736 -
Utility of CC7 Transfer in Stroke Subtypes
|
N/A | |
Completed |
NCT02969356 -
Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC)
|
Phase 4 | |
Recruiting |
NCT03402854 -
tDCS and Bimanual Therapy for Children With Hemiplegic Cerebral Palsy
|
N/A |